Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration

References

• Owens DR, Zinman B, Bolli G. Alternative routes of insulin delivery. Diab Med 2003;20:886–98
   PubMed Web of Science ®Google Scholar
• Khafagy El-S, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007;59:1521–46
   PubMed Web of Science ®Google Scholar
• Morishita M, Norishita I, Takayama K, et al. Site dependant effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on the intestinal absorption of insulin. Biol Pharm Bull 2003;16:68–72
   Google Scholar
• Morishita M, Norishita I, Takayama K, et al. Noveloral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int J Pharm 1992;78:1–7
   Web of Science ®Google Scholar
• Yamamoto A. Effect of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm Res 1994;11:1496–500
   PubMed Web of Science ®Google Scholar
• Carino GP, Jacob JS, Mathiauty E. Nanosphere based on oral insulin delivery. J Control Release 2000;65:261–9
   PubMed Web of Science ®Google Scholar
• Nakashima K, Miyagi M, Goto K, et al. Enzymatic and hyperglycemia stability of chemically modified insulin with hydrophobic acyl group. Bioorg Med Chem Lett 2004;14:481–3
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Rangaswamy V, Aminabhavi TM. pH-sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm 2011;37:977–85
   PubMed Web of Science ®Google Scholar
• Hua S, Yang H, Wang A. A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect. Drug Dev Ind Pharm 2010;36:1106–14
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, et al. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release 2008;125:193–209
   PubMed Web of Science ®Google Scholar
• Attivi D, Werhlé P, Ubrich N, et al. Formulation of insulin-loaded polymeric nanoparticles using response surface methodology. Drug Dev Ind Pharm 2005;2:177–87
   Google Scholar
• Mahjub R, Radmehr M, Dorkoosh FA, et al. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Drug Dev Ind Pharm 2014;40:1645–59
   PubMed Web of Science ®Google Scholar
• D'Souza B, Bhowmik T, Uddin MN, et al. Development of β-cyclodextrin based sustained release microparticles for oral insulin delivery. Drug Dev Ind Pharm 2014;26:1–6
   Google Scholar
• Sonia TA, Sharma CP. In vitro evaluation of N-(2-hydroxy) propyl-3-trimethyl ammonium chitosan for oral insulin delivery. Carbohydr Polym 2011;84:103–9
   Web of Science ®Google Scholar
• Mukhopadhyay P, Sarkar K, Chakraborty M, et al. Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model. Mater Sci Eng C Mater Biol Appl 2013;33:376–82
   PubMed Web of Science ®Google Scholar
• Moghassemi S, Parnian E, Hakamivala A, et al. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. Mater Sci Eng C Mater Biol Appl 2015;46:333–40
   PubMed Web of Science ®Google Scholar
• Hejazi R, Amiji M. Chitosan based gastrointestinal delivery systems. J Control Release 2003;89:151–65
   PubMed Web of Science ®Google Scholar
• MacLaughlin FC, Mumper RJ, Wang J. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 1998;56:259–72
   PubMed Web of Science ®Google Scholar
• Mao S, Shuai X, Unger F, Simon M. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm 2004;281:45–54
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43–8
   Web of Science ®Google Scholar
• Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 2001;47:57–83
   Web of Science ®Google Scholar
• Park HS, Lee JY, Cho SH, et al. Colon delivery of prednisolone based on chitosan coated polysaccharide tablets. Arch Pharm Res 2002;25:964–8
   PubMed Web of Science ®Google Scholar
• Smith J, Wood E, Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm Res 2004;21:43–9
   PubMed Web of Science ®Google Scholar
• Mao S, Bakowsky U, Jintapattanakit A, Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 2006;95:1035–48
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997;63:125–32
   Web of Science ®Google Scholar
• Maggio ET. Polysorbates, peroxides, protein aggregation and immunogenicity – a growing concern. J. Excipients Food Chem 2012;3:45–53
   Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329–47
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particles size. Pharm Res 1996;13:1838–45
   PubMed Web of Science ®Google Scholar
• Sadeghi AMM, Dorkoosh FA, Avadi MR, et al. Permeation enhance effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Eur J Pharm Biopharm 2008;70:270–8
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997;63:125–32
   Web of Science ®Google Scholar
• Snyman D, Hamman JH, Kotze AF. Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. Drug Dev Ind Pharm 2003;29:61–9
   PubMed Web of Science ®Google Scholar
• Paul W, Sharma C. Chitosan a drug carrier for the 21st century: a review. STP Pharma Sci 2000;10:5–22
   Google Scholar
• Bayat A, Larijani B, Ahmadian S, et al. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives. Nanomed Nanotechnol 2007;4:240–9
   Google Scholar
• Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier – systemic examination of fabrication condition for efficient loading and release. Colloids Surf B 2007;59:24–34
   PubMed Web of Science ®Google Scholar
• Feczko T, Toth J, Dosa G, Gyenis J. Optimization of protein encapsulation in PLGA nanoparticles. Chem Eng Process 2011;50:757–65
   Web of Science ®Google Scholar
• Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm 2008;364:328–43
   PubMed Web of Science ®Google Scholar
• Crank J. The mathematics of diffusion. Oxford: Clarendon Press; 1975
   Google Scholar
• Siepmann J, Siepmann F. Modeling of diffusion controlled drug delivery. J Control Release 2012;161:351–62
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. Mathematical modeling of controlled drug delivery. Adv Drug Deliv Rev 2001;48:137–9
   PubMed Web of Science ®Google Scholar
• Qin C, Li H, Xiao Q, et al. Water-solubility of chitosan and its antimicrobial activity. Carbohydr Polym 2006;63:367–74
   Web of Science ®Google Scholar
• Remunan-Lopez C, Bodmeier R. Mechanical, water uptake and permeability properties of crosslinked chitosan glutamate and alginate films. J Control Release 1997;44:215–25
   Web of Science ®Google Scholar